$XLC

The Virtus KAR Mid-Cap Growth Fund's Q4 2025 commentary highlights strong performance within mid-cap growth stocks, driven by positive earnings reports and robust economic conditions. The fund's managers emphasize a strategic focus on technology and healthcare sectors, indicating potential for continued growth. The commentary also notes challenges such as inflation and interest rate fluctuations, which could affect market stability. Overall, the fund has a bullish outlook, aiming for solid returns as mid-cap stocks gain momentum. Investors are advised to consider reallocating to include mid-cap growth options in their portfolios.

The Royce SMid-Cap Total Return Fund's commentary for FY 2025 indicates a cautious yet optimistic view on mid-cap stocks, suggesting potential growth in the coming year. The fund's analysis underlines a continued interest in value stocks and sectors that could benefit from economic recovery. They mention increased market volatility but reaffirm confidence in selected mid-cap firms showing resilience in their financials. The outlook includes strategic positioning to capitalize on sectors like technology and healthcare, which may experience stronger demand. Overall, the insights reflect a balanced approach, emphasizing selective investment over aggressive risks.

The Invesco Main Street Mid Cap Fund's Q4 2025 commentary reveals a cautious outlook for mid-cap stocks, emphasizing potential headwinds from rising interest rates and inflation concerns. Despite these challenges, the fund highlights opportunities in sectors such as technology and healthcare due to strong earnings growth. The commentary suggests a selective approach to mid-cap investments, focusing on companies with robust business models. Additionally, management noted that mid-cap stocks might outperform their large-cap counterparts if economic conditions stabilize. Overall, the tone suggests a mixture of caution and selective optimism regarding mid-cap investments going into 2026.

Navan is facing a shareholder lawsuit that claims the company presented materially misleading information during its IPO process. This legal challenge could have significant implications for its stock price and investor confidence. The allegations arise from discrepancies in the financial data shared with potential investors. If proven true, it could lead to regulatory scrutiny and possible penalties for Navan. Investors may reassess their positions in Navan based on the lawsuit's developments.